Disclosed are compositions and methods for producing fusion proteins with reduced immunogenicity. Fusion proteins of the invention include a junction region having an amino acid change that reduces the ability of a junctional epitope to bind to MHC Class II, thereby reducing its interaction with a T-cell receptor. Methods of the invention involve analyzing, changing, or modifying one or more amino acids in the junction region of a fusion protein in order to identify a T-cell epitope and reduce its ability to interact with a T cell receptor. Compositions and methods of the invention are useful in therapy.

 
Web www.patentalert.com

< Novel Bacillus Thuringiensis Gene with Lepidopteran Activity

> Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes

> Dietary supplement including He Shou Wu, parasitic loranthus and green tea to promote weight loss

~ 00549